Truls Gårdmark
Impact in
Papers in
- Co-authors
- Per‐Uno Malmström (31 shared papers)Staffan Jahnson (27 shared papers)Kenneth Wester (2 shared papers)Jörgen Carlsson (2 shared papers)Fredrik Liedberg (30 shared papers)Manuel de la Torre (2 shared papers)Viveka Ströck (32 shared papers)Firas Aljabery (29 shared papers)
- Journals
- British Journal of Urology (7 papers)The Journal of Urology (3 papers)PLoS ONE (3 papers)BMJ Open (2 papers)Cancer Medicine (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Truls Gårdmark
45 papers receiving 519 citations
Peers
Comparison fields: 5 of 54
- Urology 105
- Surgery 380
- Oncology 185
- Immunology 57
- Biotechnology 19
Countries citing papers authored by Truls Gårdmark
This map shows the geographic impact of Truls Gårdmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Truls Gårdmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Truls Gårdmark more than expected).
Fields of papers citing papers by Truls Gårdmark
This network shows the impact of papers produced by Truls Gårdmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Truls Gårdmark. The network helps show where Truls Gårdmark may publish in the future.
Co-authors
The 25 scholars most cited alongside Truls Gårdmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 84 | |
| 2 | 2005 | 47 | |
| 3 | 2014 | 41 | |
| 4 | 2017 | 40 | |
| 5 | 2007 | 38 | |
| 6 | 2019 | 35 | |
| 7 | 2005 | 28 | |
| 8 | 2006 | 25 | |
| 9 | 2014 | 23 | |
| 10 | 2019 | 18 | |
| 11 | 2019 | 14 | |
| 12 | 2021 | 11 | |
| 13 | 2019 | 11 | |
| 14 | 2020 | 10 | |
| 15 | 2022 | 10 | |
| 16 | 2022 | 8 | |
| 17 | 2019 | 8 | |
| 18 | 2018 | 7 | |
| 19 | 2019 | 6 | |
| 20 | 2021 | 6 |
About Truls Gårdmark
Truls Gårdmark is a scholar working on Surgery, Urology, Oncology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 522 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (45 papers), Urinary and Genital Oncology Studies (29 papers), Urological Disorders and Treatments (14 papers), Colorectal Cancer Screening and Detection (9 papers), Esophageal Cancer Research and Treatment (7 papers), Urinary Bladder and Prostate Research (5 papers), Urinary Tract Infections Management (4 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Urology (105 citations), Surgery (380 citations), Oncology (185 citations), Immunology (57 citations) and Biotechnology (19 citations). Truls Gårdmark has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Per‐Uno Malmström, Staffan Jahnson, Kenneth Wester, Jörgen Carlsson, Fredrik Liedberg, Manuel de la Torre, Viveka Ströck, Firas Aljabery, Amir Sherif and Abolfazl Hosseini. Their work appears in journals such as British Journal of Urology, The Journal of Urology, PLoS ONE, BMJ Open and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.